tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsBuy Rating for CG Oncology: Creto’s Market Potential and Strategic Pricing Flexibility
7d ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
13d ago
Premium
Company Announcements
CG Oncology Highlights Drug Potential at Healthcare Conference
13d ago
PremiumRatingsPromising Phase 3 Results for CG Oncology’s Cretostimogene Highlight Competitive Edge in Bladder Cancer Treatment
14d ago
Premium
Ratings
Promising Outlook for CG Oncology, Inc.: Buy Rating Supported by Cretostimogene’s Efficacy and Market Potential
17d ago
Premium
Company Announcements
CG Oncology Announces Promising Phase 3 Trial Results
17d ago
PremiumRatingsCG Oncology’s Strategic Advancements and Promising Data Reinforce Buy Rating
1M ago
CG Oncology price target lowered to $62 from $63 at BofA
Premium
The Fly
CG Oncology price target lowered to $62 from $63 at BofA
1M ago
Premium
Company Announcements
CG Oncology’s Q2 2025: Clinical Advances and Legal Wins
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100